Arena Pharmaceuticals Inc
ARNADelisted Mar 11, 2022- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001080709
Arena Pharmaceuticals Inc was delisted on Mar 11, 2022; its insiders filed their last Form 4 on Mar 11, 2022; 317 institutions reported holding it in 13F filings for Q4 2021, worth $4.87B in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Arena Pharmaceuticals Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Arena Pharmaceuticals Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Fetzer Oliver | Director | 0 | Mar 11, 2022 | 0 |
| Nova Tina Susan | Director | 0 | Mar 11, 2022 | 0 |
| Gallahue Kieran | Director | 0 | Mar 11, 2022 | 0 |
| Neil Garry Arthur | Director | 0 | Mar 11, 2022 | 0 |
| Munshi Amit | President and CEO | 0 | Mar 11, 2022 | 0 |
| Stelzer Laurie | EVP & Chief Financial Officer | 0 | Mar 11, 2022 | 0 |
| Dallas Jayson Donald Alexander | Director | 0 | Mar 11, 2022 | 0 |
| Aurentz Vincent | Executive VP and CBO | 0 | Mar 11, 2022 | 0 |
| Jarrett Jennifer | Director | 0 | Mar 11, 2022 | 0 |
| Knobil Katharine | Director | 0 | Mar 11, 2022 | 0 |
| Lisicki Robert | EVP, Chief Commercial Officer | 0 | Mar 11, 2022 | 0 |
| Schmidt Joan | EVP, General Counsel & Sec | 0 | Mar 11, 2022 | 0 |
| Ouzren Nawal | Director | 0 | Mar 11, 2022 | 0 |
| Schoch Steven J | Director | 0 | Mar 11, 2022 | 0 |
| Manion Douglas J. | EVP Research & Development | 0 | Mar 11, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2021 (view filing) | Aug 16 | 1 day | Munshi AmitPresident and CEO | PPurchase | +1.00K | $48.19 | +$48.2K | +2.6%39.5K after | |
| Aug 13, 2021 (view filing) | Aug 12 | 1 day | Munshi AmitPresident and CEO | PPurchase | +1.00K | $50.41 | +$50.4K | +2.7%38.5K after | |
| Aug 11, 2021 (view filing) | Aug 10 | 1 day | Munshi AmitPresident and CEO | PPurchase | +1.00K | $52.92 | +$52.9K | +2.7%37.5K after | |
| Aug 5, 2021 (view filing) | Aug 3 | 2 days | Lisicki RobertEVP, Chief Commercial Officer | SSale | −17.5K | $60.08 | −$1.05M | −52.1%16.1K after | 2 lots |